CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $93,804 | -36.2% | 4,052 | -27.8% | 0.05% | -32.5% |
| Q4 2022 | $146,982 | +14.8% | 5,610 | -13.6% | 0.08% | +51.0% |
| Q3 2022 | $128,000 | +13.3% | 6,490 | +0.8% | 0.05% | +21.4% |
| Q2 2022 | $113,000 | -34.3% | 6,441 | -38.9% | 0.04% | -45.5% |
| Q1 2022 | $172,000 | -5.5% | 10,536 | -5.6% | 0.08% | +11.6% |
| Q4 2021 | $182,000 | +13.0% | 11,158 | -11.7% | 0.07% | -2.8% |
| Q3 2021 | $161,000 | -14.4% | 12,632 | -5.0% | 0.07% | -7.8% |
| Q2 2021 | $188,000 | – | 13,299 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |